Ireland Stroke Treatment Market to be dominated by Generic Drugs through 2028
Rising
prevalence of cardiovascular diseases is expected to drive the Ireland stroke
treatment market in the forecast period, 2024-2028.
According
to TechSci Research report, “Ireland Stroke Treatment Market - By Region,
Competition, Forecast and Opportunities, 2028”, the Ireland stroke
treatment market is expected to grow at an impressive rate during the forecast
period, 2018-2028. The rising prevalence of cardiovascular diseases, increase
in healthcare awareness, rise in incidence of diabetes, surge in number of
tobacco users, and growth in geriatric population are the primary factors
driving the demand for the Ireland stroke treatment market. Additionally, the
government of Ireland is providing enormous amount of funds for the development
of drugs and therapies for the treatment of chronic diseases such as
cardiovascular disease, cancer, diabetes, etc.
However,
the skilled healthcare professionals and advancement in technologies also
enhanced the growth of Ireland stroke treatment market in the forecast period.
Additionally, the ongoing research and development activities in stroke
treatment contribute to advancements in therapies, pharmaceuticals, and
rehabilitation techniques. Academic institutions, research organizations, and
industry collaborations drive innovative solutions aimed at improving stroke
care outcomes. Clinical trials and studies help in identifying new treatment
approaches, evaluating the effectiveness of interventions, and enhancing
patient care, thereby, boosting the growth of Ireland stroke treatment market.
Moreover, the recognition of the importance of post-stroke rehabilitation and
recovery has driven the expansion of rehabilitation services. Stroke survivors
require comprehensive rehabilitation programs encompassing physical,
occupational, and speech therapy to regain their independence and improve their
quality of life. This focus on holistic care drives the market for
rehabilitation services and technologies. Therefore, these factors are
responsible for expecting the growth of Ireland stroke treatment market.
One
of the major restraints limiting the growth of stroke treatment market is high
cost of diagnosis and treatments, and lack of reimbursement policies. These
factors are expected to hinder the growth of Ireland stroke treatment market.
The Irish government had also launched campaigns to raise awareness in
lifestyle regarding cardiovascular diseases among healthcare professionals and
patients.
Browse
over XX Market Data Figures spread through XX Pages and an in-depth TOC on
"Ireland Stroke Treatment Market.”
The
Ireland stroke treatment market is segmented is segmented by type, application,
distribution channel, regional distribution, and competitional landscape.
Based
on type, the market is further bifurcated into diagnostics and therapeutics.
The diagnostics segment has dominated the market in 2022. This is ascribed to
less technological advancement in the stroke management devices, rise in
incident rate of chronic diseases such as like hypertension, cardiovascular
diseases, diabetes, etc.
Based
on application, the market is segmented into ischemic stroke and hemorrhagic
stroke. The ischemic stroke segment has dominated the market in 2022. It will
further dominate the market in forecast period as well. This is due to the
increase in healthcare awareness, rise in incidence of diabetes, surge in
number of tobacco users, and growth in geriatric population.
Based
on distribution channel, the market is bifurcated into hospital pharmacies,
retail pharmacies, and online pharmacies. The hospital pharmacies segment
dominated the market in 2022 and will also become a major contributor in
forecast period. This is due to the ease in facilities, smooth treatment, and
rise in number of pharmacies in hospital.
Major
companies operating in Ireland stroke treatment market include:
- Boston
Scientific Corporation Ireland Ltd.
- Braun
Ireland Limited
- Bristol
Myers Squibb Co.
- Cardinal
Health Ireland Limited
- GlaxoSmithKline
Ireland
- Abbott
Ireland Limited
- Medtronic
Ireland Ltd.
- Merck
Serono Limited
- Johnson
& Johnson Ireland Limited
- Siemens
Ireland Limited
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Ireland
stroke treatment market is expected to witness significant growth during the
forecast period on account of increasing geriatric population. An increase in
number of cardiovascular diseases, lifestyle diseases, and accelerating demand
for medical tourism is expected to grow the Ireland stroke treatment market.
Additionally, the technological advancements and rising public awareness
regarding blood clot formation, are expected to hamper the market growth in the
next few years” said Mr. Karan Chechi, Research Director with TechSci Research,
a research-based global management consulting firm.
“Ireland
Stroke Treatment Market, By Type (Diagnostics, Therapeutics), By Application
(Ischemic Stroke, Hemorrhagic Stroke), By Distribution Channel (Hospital
Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region, Competition,
Forecast and Opportunities, 2028”,
has evaluated the future growth potential of Ireland stroke treatment market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Ireland stroke treatment market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com